Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

被引：0
|
作者：
Tsugiko Oze
Naoki Hiramatsu
Nao Kurashige
Natsuko Tsuda
Takayuki Yakushijin
Tatsuya Kanto
Tetsuo Takehara
Akinori Kasahara
Michio Kato
Harumasa Yoshihara
Kazuhiro Katayama
Shinji Kubota
Taizo Hijioka
Kazunobu Ishibashi
Masahide Oshita
Hideki Hagiwara
Yoshimichi Haruna
Eiji Mita
Shinji Tamura
Norio Hayashi
机构：
[1] Osaka University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] National Hospital Organization Osaka National Hospital,undefined
[3] Osaka Rousai Hospital,undefined
[4] Osaka Kouseinenkin Hospital,undefined
[5] Kansai Rousai Hospital,undefined
[6] National Hospital Organization Osaka Minami Medical Center,undefined
[7] Kaizuka City Hospital,undefined
[8] Osaka Police Hospital,undefined
[9] Higashiosaka City Central Hospital,undefined
[10] Osaka General Medical Center,undefined
[11] Saiseikai Senri Hospital,undefined
来源：
Journal of Gastroenterology | 2006年 / 41卷
关键词：
chronic hepatitis C; interferon and ribavirin combination therapy; progression of anemia; “2 by 2” standard;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：862 / 872
页数：10
相关论文
共 50 条
  • [1] Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Kurashige, Nao
    Tsuda, Natsuko
    Yakushijin, Takayuki
    Kanto, Tatsuya
    Takehara, Tetsuo
    Kasahara, Akinori
    Kato, Michio
    Yoshihara, Harumasa
    Katayama, Kazuhiro
    Kubota, Shinji
    Hijioka, Taizo
    Ishibashi, Kazunobu
    Oshita, Masahide
    Hagiwara, Hideki
    Haruna, Yoshimichi
    Mita, Eiji
    Tamura, Shinji
    Hayashi, Norio
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (09) : 862 - 872
  • [2] Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Hiramatsu, Naoki
    Kurashige, Nao
    Oze, Tsugiko
    Takehara, Tetsuo
    Tamura, Shinji
    Kasahara, Akinori
    Oshita, Masahide
    Katayama, Kazuhiro
    Yoshihara, Harumasa
    Imai, Yasuharu
    Kato, Michio
    Kawata, Sumio
    Tsubouchi, Hirohito
    Kumada, Hiromitsu
    Okanoue, Takeshi
    Kakumu, Shinichi
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2008, 38 (01) : 52 - 59
  • [3] Ribavirin-induced hemolytic anemia in chronic hepatitis C patients
    Yoshito Itoh
    Takeshi Okanoue
    Journal of Gastroenterology, 2004, 39 : 704 - 705
  • [4] Ribavirin-induced hemolytic anemia in chronic hepatitis C patients
    Itoh, Y
    Okanoue, T
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (07) : 704 - 705
  • [5] Ribavirin-induced hemolytic anemia in patients with chronic hepatitis C (HCV).
    Duca, L
    De Feo, TM
    Mattioli, M
    Molteni, V
    Di Masi, V
    Cappellini, MD
    Fargion, S
    Fiorelli, G
    BLOOD, 1998, 92 (10) : 4B - 4B
  • [6] Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination Therapy
    Krishnan, Sheeja M.
    Dixit, Narendra M.
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (02)
  • [7] Does smoking effect ribavirin-induced anemia during combination therapy in hepatitis C patients?.
    Patel, K
    McHutchison, JG
    Heaton, S
    Behling, CA
    Bylund, D
    Pockros, PJ
    Blatt, LM
    HEPATOLOGY, 2001, 34 (04) : 604A - 604A
  • [8] Modeling Ribavirin-Induced Anemia in Patients With Chronic Hepatitis C Virus
    Wu, L. S.
    Jimmerson, L. C.
    MacBrayne, C. E.
    Kiser, J. J.
    D'Argenio, D. Z.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (02): : 65 - 73
  • [9] Early prediction of development of severe anemia by serum ribavirin levels during interferon and ribavirin combination therapy for chronic hepatitis C
    Igarashi, H.
    Shinozaki, S.
    LIVER INTERNATIONAL, 2006, 26 : 78 - 79
  • [10] Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
    Ferenci, P
    Stauber, R
    Hackl, F
    Schuetze, K
    Bauer, B
    Datz, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1437 - A1437
12345